Sunjong Kwon
Head of R&D Centre EyeGene
Dr. Sunjong Kwon, Head of the R&D Center at EyeGene Inc., leads innovation in Gene and Cell Therapy. With prior roles at Oregon Health & Science University and Harvard Medical School, he brings deep expertise in translational science and platform development. His current work advances next generation RNA medicines and vaccines, driving progress in delivery, efficacy, and clinical translation.
Seminars
Thursday 12th November 2026
Preclinical Study of a COVID-19 Vaccine Candidate Based on a Next-Generation Korean Self-Amplifying RNA (saRNA) Platform
11:30 am
- Exploring immunogenicity and protective efficacy of a next-generation self-amplifying RNA COVID-19 vaccine candidate
- Discussing biodistribution and nonclinical safety assessment supporting preclinical development
- Unveiling CMC development and process optimization toward clinical translation
